HK1001763A1 - Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate - Google Patents
Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginateInfo
- Publication number
- HK1001763A1 HK1001763A1 HK98100847A HK98100847A HK1001763A1 HK 1001763 A1 HK1001763 A1 HK 1001763A1 HK 98100847 A HK98100847 A HK 98100847A HK 98100847 A HK98100847 A HK 98100847A HK 1001763 A1 HK1001763 A1 HK 1001763A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- alginate
- dosage forms
- pharmaceutical dosage
- proton pump
- oral pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9600071A SE9600071D0 (sv) | 1996-01-08 | 1996-01-08 | New oral formulation of two active ingredients I |
PCT/SE1996/001737 WO1997025066A1 (en) | 1996-01-08 | 1996-12-20 | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1001763A1 true HK1001763A1 (en) | 1998-07-10 |
Family
ID=20400969
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98100847A HK1001763A1 (en) | 1996-01-08 | 1998-02-05 | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
HK98111792A HK1017992A1 (en) | 1996-01-08 | 1998-11-06 | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98111792A HK1017992A1 (en) | 1996-01-08 | 1998-11-06 | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
Country Status (35)
Country | Link |
---|---|
US (1) | US6183776B1 (tr) |
EP (1) | EP0813424B2 (tr) |
JP (1) | JPH11501950A (tr) |
KR (1) | KR100490075B1 (tr) |
CN (1) | CN1080125C (tr) |
AR (1) | AR005281A1 (tr) |
AT (1) | ATE228009T1 (tr) |
AU (1) | AU712669B2 (tr) |
BR (1) | BR9607350B1 (tr) |
CA (1) | CA2213996C (tr) |
CZ (1) | CZ293583B6 (tr) |
DE (1) | DE69624907T3 (tr) |
DK (1) | DK0813424T4 (tr) |
EE (1) | EE04002B1 (tr) |
EG (1) | EG23821A (tr) |
ES (1) | ES2185817T5 (tr) |
HK (2) | HK1001763A1 (tr) |
HU (1) | HU229153B1 (tr) |
IL (1) | IL121651A (tr) |
IS (1) | IS2716B (tr) |
MX (1) | MX9706785A (tr) |
MY (1) | MY116091A (tr) |
NO (1) | NO326656B1 (tr) |
NZ (1) | NZ325977A (tr) |
PL (1) | PL187075B1 (tr) |
PT (1) | PT813424E (tr) |
RU (1) | RU2179453C2 (tr) |
SA (1) | SA97170553B1 (tr) |
SE (1) | SE9600071D0 (tr) |
SK (1) | SK283695B6 (tr) |
TR (1) | TR199700916T1 (tr) |
TW (1) | TW464514B (tr) |
UA (1) | UA45392C2 (tr) |
WO (1) | WO1997025066A1 (tr) |
ZA (1) | ZA9610935B (tr) |
Families Citing this family (124)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US20050054682A1 (en) * | 1996-01-04 | 2005-03-10 | Phillips Jeffrey O. | Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same |
US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
SE9600071D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
JP2001509791A (ja) * | 1996-11-27 | 2001-07-24 | ザ、プロクター、エンド、ギャンブル、カンパニー | 胃腸障害の治療用組成物及び方法 |
MX9703918A (es) * | 1997-05-28 | 1998-11-30 | J Marshall M D Barry | Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior. |
SE510650C2 (sv) * | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
WO1999010000A1 (en) * | 1997-08-25 | 1999-03-04 | The Procter & Gamble Company | Combined preparations for treating upper gastrointestinal tract distress |
AU751066B2 (en) * | 1997-12-08 | 2002-08-08 | Nycomed Gmbh | Novel administration form comprising an acid-labile active compound |
SE9704869D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulaton II |
SE9704870D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
FR2774906B1 (fr) * | 1998-02-13 | 2000-05-12 | Rhodia Chimie Sa | Systeme d'encapsulation a coeur organique et a ecorce minerale a base d'hydroxycarbonate d'aluminium et son procede de preparation |
KR100554924B1 (ko) * | 1998-05-18 | 2006-03-03 | 다케다 야쿠힌 고교 가부시키가이샤 | 구강내 붕괴 정제 |
US7122207B2 (en) | 1998-05-22 | 2006-10-17 | Bristol-Myers Squibb Company | High drug load acid labile pharmaceutical composition |
UA69413C2 (uk) * | 1998-05-22 | 2004-09-15 | Брістол-Майерс Сквібб Компані | Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції |
DE69924381T2 (de) | 1998-07-28 | 2006-04-20 | Takeda Pharmaceutical Co. Ltd. | Leicht zerfallende feste zubereitung |
SE9803772D0 (sv) * | 1998-11-05 | 1998-11-05 | Astra Ab | Pharmaceutical formulation |
IL145688A0 (en) * | 1999-03-29 | 2002-06-30 | American Home Prod | Coating system |
JP2003504338A (ja) * | 1999-07-12 | 2003-02-04 | スミスクライン・ビーチャム・コーポレイション | 胸やけの処置法 |
JP4081273B2 (ja) | 1999-10-20 | 2008-04-23 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ベンズイミダゾール系化合物安定化方法 |
US20040191276A1 (en) * | 1999-11-30 | 2004-09-30 | Cutispharma, Inc. | Compositions and kits for compounding pharmaceuticals |
US20020064555A1 (en) * | 2000-09-29 | 2002-05-30 | Dan Cullen | Proton pump inhibitor formulation |
US20020192299A1 (en) * | 2000-12-28 | 2002-12-19 | Rajneesh Taneja | Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
SE0101379D0 (sv) * | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
IL159584A0 (en) * | 2001-07-16 | 2004-06-01 | Astrazeneca Ab | Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
AR036354A1 (es) * | 2001-08-31 | 2004-09-01 | Takeda Chemical Industries Ltd | Preparacion solida |
DE60237294D1 (de) * | 2001-09-28 | 2010-09-23 | Mcneil Ppc Inc | Pharmazeutische zusammensetzung auf fondantbasis |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
US7008777B2 (en) | 2001-10-15 | 2006-03-07 | Barry J. Marshall | System for the detection of urease and method for using same |
CA2472103A1 (en) * | 2002-01-25 | 2003-08-07 | Santarus, Inc. | Transmucosal delivery of proton pump inhibitors |
KR100479637B1 (ko) * | 2002-02-01 | 2005-03-31 | 한국화학연구원 | 란소프라졸을 함유하는 경구제제 및 그의 제조방법 |
CO5400144A1 (es) * | 2002-03-11 | 2004-05-31 | Novartis Ag | Compuestos organicos |
PT1492511E (pt) | 2002-04-09 | 2009-04-09 | Flamel Tech Sa | Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s) |
US20030228363A1 (en) * | 2002-06-07 | 2003-12-11 | Patel Mahendra R. | Stabilized pharmaceutical compositons containing benzimidazole compounds |
US20040081700A1 (en) * | 2002-07-03 | 2004-04-29 | Rajneesh Taneja | Dose titratable liquid dosage forms of acid labile drugs |
US20040082618A1 (en) * | 2002-07-03 | 2004-04-29 | Rajneesh Taneja | Liquid dosage forms of acid labile drugs |
US6663892B1 (en) * | 2002-08-19 | 2003-12-16 | L. Perrigo Company | Multiple portion tablet |
ES2534713T3 (es) * | 2002-10-16 | 2015-04-27 | Takeda Pharmaceutical Company Limited | Preparaciones sólidas estables |
MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
SE0203065D0 (sv) | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
US9107804B2 (en) * | 2002-12-10 | 2015-08-18 | Nortec Development Associates, Inc. | Method of preparing biologically active formulations |
US20040121004A1 (en) * | 2002-12-20 | 2004-06-24 | Rajneesh Taneja | Dosage forms containing a PPI, NSAID, and buffer |
US20070243251A1 (en) * | 2002-12-20 | 2007-10-18 | Rajneesh Taneja | Dosage Forms Containing A PPI, NSAID, and Buffer |
US8367111B2 (en) * | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
US20040166162A1 (en) * | 2003-01-24 | 2004-08-26 | Robert Niecestro | Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid |
US7258981B2 (en) * | 2003-01-24 | 2007-08-21 | Clontech Laboratories, Inc. | Sensitive proteasome sensor constructs and methods for their design and use |
CA2517005A1 (en) * | 2003-02-20 | 2004-09-02 | Santarus, Inc. | A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
EP1759692A3 (en) * | 2003-03-10 | 2007-09-12 | Novartis AG | Taste-masked solid veterinary compositions |
KR101173580B1 (ko) * | 2003-03-18 | 2012-08-13 | 코와 가부시키가이샤 | 제산제 조성물 |
US8802139B2 (en) * | 2003-06-26 | 2014-08-12 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
CA2531566C (en) * | 2003-07-18 | 2013-05-07 | Santarus, Inc. | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
JP2006528181A (ja) * | 2003-07-18 | 2006-12-14 | サンタラス インコーポレイティッド | 酸分泌を阻害するために有用な薬学的製剤ならびにそれらを作製および使用する方法 |
US20060165793A1 (en) * | 2003-08-04 | 2006-07-27 | Koji Ukai | Pharmaceutical preparation to be dispersed before administration |
US7282050B2 (en) * | 2003-10-31 | 2007-10-16 | Medtronic, Inc. | Ablation of exterior of stomach to treat obesity |
US7252665B2 (en) * | 2003-10-31 | 2007-08-07 | Medtronic, Inc | Ablation of stomach lining to reduce stomach acid secretion |
US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
US7041124B2 (en) * | 2003-12-23 | 2006-05-09 | Kimberly-Clark Worldwide, Inc. | System and method for providing therapy to a portion of a body |
GB0403165D0 (en) * | 2004-02-12 | 2004-03-17 | Ct | Novel uses for proton pump inhibitors |
US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
CA2569961A1 (en) * | 2004-06-10 | 2005-12-29 | Glatt Air Techniques, Inc | Controlled release pharmaceutical formulation |
US20050281876A1 (en) * | 2004-06-18 | 2005-12-22 | Shun-Por Li | Solid dosage form for acid-labile active ingredient |
US8394409B2 (en) * | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
GB2418854B (en) * | 2004-08-31 | 2009-12-23 | Euro Celtique Sa | Multiparticulates |
US8747895B2 (en) * | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
EP1802285B1 (en) | 2004-10-21 | 2013-02-27 | Aptalis Pharmatech, Inc. | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
US20060165797A1 (en) * | 2005-01-12 | 2006-07-27 | Pozen Inc. | Dosage form for treating gastrointestinal disorders |
US8673352B2 (en) | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
SE530605C2 (sv) * | 2005-09-29 | 2008-07-15 | Barbara Nelson | Läkemedel innehållande ett syrahämmande medel, avseende att användas för att motverka och bota luftvägssjukdomar |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
MY151468A (en) * | 2005-12-28 | 2014-05-30 | Takeda Pharmaceutical | Controlled release solid preparation |
CN101453993A (zh) * | 2006-04-03 | 2009-06-10 | 伊萨·奥迪迪 | 含有机溶胶涂层的受控释放递送物件 |
US20090068263A1 (en) * | 2006-04-20 | 2009-03-12 | Themis Laboratories Private Limited | Multiple unit compositions |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
WO2007138606A2 (en) * | 2006-06-01 | 2007-12-06 | Dexcel Pharma Technologies Ltd. | Multiple unit pharmaceutical formulation |
AR056062A1 (es) | 2006-06-05 | 2007-09-19 | Bago Sa Labor | Composicion farmaceutica antiacida en forma de polvo, preparacion farmaceutica que la comprende y proceso para su preparacion |
CN101120930B (zh) * | 2006-08-11 | 2010-09-29 | 石药集团中奇制药技术(石家庄)有限公司 | 一种奥美拉唑组合物及其制备方法 |
US20090092658A1 (en) * | 2007-10-05 | 2009-04-09 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
MX2009004475A (es) | 2006-10-27 | 2009-08-12 | Univ Missouri | Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma. |
US20080194307A1 (en) * | 2007-02-13 | 2008-08-14 | Jeff Sanger | Sports-based game of chance |
CN101259140B (zh) * | 2007-03-08 | 2012-08-22 | 重庆北碚现代应用药物研究所 | 一种治疗胃炎、胃溃疡及十二指肠溃疡的复方药物及其制备方法 |
ES2759626T3 (es) * | 2007-05-07 | 2020-05-11 | Evonik Operations Gmbh | Formas farmacéuticas sólidas que comprenden un recubrimiento entérico con liberación acelerada del fármaco |
EP2044929A1 (en) * | 2007-10-04 | 2009-04-08 | Laboratorios del Dr. Esteve S.A. | Oral fast distintegrating tablets |
ITFI20070253A1 (it) * | 2007-11-09 | 2009-05-10 | Valpharma Internat S P A | Formulazioni farmaceutiche per la somministrazione di ipp. |
CA2716367C (en) | 2008-02-20 | 2015-05-26 | The Curators Of The University Of Missouri | Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same |
EP2127643A1 (de) * | 2008-05-30 | 2009-12-02 | Bayer Schering Pharma Aktiengesellschaft | Orale Pelletformulierungen mit zeitversetzter Wirkstofffreigabe |
CA2736547C (en) | 2008-09-09 | 2016-11-01 | Pozen Inc. | Method for delivering a pharmaceutical composition to patient in need thereof |
WO2010038241A2 (en) * | 2008-09-30 | 2010-04-08 | Panacea Biotec Limited | Pharmaceutical compositions comprising of proton pump inhibitor, prokinetic agent and alginic acid |
JP2012072061A (ja) * | 2009-01-29 | 2012-04-12 | Eisai R & D Management Co Ltd | 新規組成物 |
EA021112B1 (ru) * | 2009-06-25 | 2015-04-30 | Поузен Инк. | Способ лечения боли и/или воспаления у пациента, нуждающегося в аспириновой терапии |
MX2011013467A (es) | 2009-06-25 | 2012-02-13 | Astrazeneca Ab | Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine). |
TWI471146B (zh) | 2009-12-02 | 2015-02-01 | Aptalis Pharma Ltd | 菲索特芬那定(fexofenadine)微膠囊及包含其之組合物 |
WO2011080502A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
WO2011080500A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
EP2519229A2 (en) | 2009-12-29 | 2012-11-07 | Novartis AG | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
US20110212171A1 (en) * | 2010-01-08 | 2011-09-01 | Eurand, Inc. | Taste masked topiramate composition and an orally disintegrating tablet comprising the same |
KR20130091250A (ko) | 2010-04-23 | 2013-08-16 | 에스-바이오텍 홀딩 에이피에스 | 위산 중화용 고체 약학 조성물 |
WO2013101897A2 (en) | 2011-12-28 | 2013-07-04 | Pozen Inc. | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
US20140127296A1 (en) * | 2012-11-05 | 2014-05-08 | Kenneth John Tibbs | Pharmaceutical preparation and method for treatment of diabetes |
US20150238514A1 (en) * | 2014-02-21 | 2015-08-27 | William Armstrong | Protective Supplement Configuration |
WO2016174664A1 (en) * | 2015-04-29 | 2016-11-03 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
SG11201809555QA (en) * | 2016-04-29 | 2018-11-29 | Alan Thompson | Veterinary composition |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
TR201723199A2 (tr) * | 2017-12-30 | 2019-07-22 | Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi | Yeni farmasötik bileşimler. |
KR102080023B1 (ko) | 2018-01-29 | 2020-02-21 | 주식회사 종근당 | 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물 |
KR102006777B1 (ko) * | 2018-01-29 | 2019-10-08 | 주식회사 종근당 | 에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제 |
CN112839635A (zh) * | 2018-08-23 | 2021-05-25 | 株式会社钟根堂 | 包含埃索美拉唑及碳酸氢钠的具有优秀的释放特性的药剂学制剂 |
BR112022007223A2 (pt) * | 2019-10-17 | 2022-07-05 | Hanmi Pharm Ind Co Ltd | Composição farmacêutica e formulação de combinação farmacêutica |
CN114980867B (zh) * | 2020-01-23 | 2024-03-15 | 韩美药品株式会社 | 包含质子泵抑制剂和抗酸剂的药物复合制剂 |
BR112022014430A2 (pt) * | 2020-01-23 | 2022-09-13 | Hanmi Pharm Ind Co Ltd | Formulação farmacêutica composta |
KR102608889B1 (ko) * | 2020-07-14 | 2023-12-04 | 한미약품 주식회사 | 프로톤 펌프 저해제 및 제산제를 포함하는 약제학적 복합제제 및 그의 제조방법 |
KR20220065997A (ko) * | 2020-11-13 | 2022-05-23 | (주)휴온스 | 라베프라졸 및 제산제를 포함하는 약제학적 복합제제 및 이의 제조방법 |
CN114569579B (zh) | 2020-12-02 | 2023-10-31 | 丽珠医药集团股份有限公司 | 肠溶微丸、其制备方法和包含它的制剂 |
KR20230097346A (ko) * | 2021-12-24 | 2023-07-03 | 한미약품 주식회사 | 프로톤 펌프 저해제 및 제산제를 포함하는 경구용 복합정제의 제조방법 및 이에 의해 제조된 경구용 복합정제 |
KR102553713B1 (ko) * | 2022-11-18 | 2023-07-10 | 고덕상 | 미네랄 촉매제를 이용한 양식어류사료 제조방법 |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5535031A (en) | 1978-09-04 | 1980-03-11 | Shin Etsu Chem Co Ltd | Enteric coating composition |
JPS5598120A (en) | 1979-01-16 | 1980-07-25 | Shin Etsu Chem Co Ltd | Preparation of drug having enteric coating |
FR2471186A1 (fr) | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
US4340582A (en) | 1981-01-15 | 1982-07-20 | Abbott Laboratories | Erythromycin base tablets |
US4377568A (en) | 1981-08-12 | 1983-03-22 | Merck Sharp & Dohme (I.A.) Corp. | Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same |
DK150008C (da) | 1981-11-20 | 1987-05-25 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat |
JPS5973529A (ja) | 1982-10-12 | 1984-04-25 | Sankyo Co Ltd | 被覆固形製剤の製造法 |
US4525339A (en) | 1982-10-15 | 1985-06-25 | Hoffmann-La Roche Inc. | Enteric coated oral dosage form |
US4518433A (en) | 1982-11-08 | 1985-05-21 | Fmc Corporation | Enteric coating for pharmaceutical dosage forms |
GB2132887A (en) | 1982-11-15 | 1984-07-18 | Procter & Gamble | Enteric-coated anti-inflammatory compositions |
US4556552A (en) | 1983-09-19 | 1985-12-03 | Colorcon, Inc. | Enteric film-coating compositions |
WO1985003436A1 (en) | 1984-02-10 | 1985-08-15 | A/S Alfred Benzon | Diffusion coated multiple-units dosage form |
US4568560A (en) | 1984-03-16 | 1986-02-04 | Warner-Lambert Company | Encapsulated fragrances and flavors and process therefor |
SE450087B (sv) | 1985-10-11 | 1987-06-09 | Haessle Ab | Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial |
WO1987004077A1 (en) | 1986-01-03 | 1987-07-16 | The University Of Melbourne | Gastro-oesophageal reflux composition |
US5112813A (en) | 1986-03-07 | 1992-05-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Process for the preparation of a viscosity-stable antacid composition |
GB2189698A (en) † | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
DK179687D0 (da) | 1987-04-08 | 1987-04-08 | Farma Food As | Praeparat |
KR960011236B1 (ko) † | 1987-05-08 | 1996-08-21 | 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 | 제약학적 조성물 및 고체 제형 |
EP0294933B1 (en) † | 1987-05-08 | 1992-03-11 | Smith Kline & French Laboratories Limited | Pharmaceutical compositions |
GB8809421D0 (en) * | 1988-04-21 | 1988-05-25 | Fordonal Sa | Antacid compositions with prolonged gastric residence time |
DE3931215C2 (de) | 1988-09-20 | 1998-07-16 | Glaxo Group Ltd | Pharmazeutische Präparate auf der Grundlage von Ranitidin |
SE8803822D0 (sv) * | 1988-10-26 | 1988-10-26 | Novel dosage form | |
US5026559A (en) | 1989-04-03 | 1991-06-25 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
DE4023028A1 (de) * | 1990-07-20 | 1992-01-23 | Hoechst Ag | Ferroelektrische fluessigkristalline si-enthaltende copolymere, ein verfahren zu ihrer herstellung, mischungen dieser copolymere mit niedermolekularen fluessigkristallen und die verwendung in elektrooptischen bauteilen |
US5244670A (en) * | 1991-04-04 | 1993-09-14 | The Procter & Gamble Company | Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress |
IT1251153B (it) | 1991-08-06 | 1995-05-04 | Vectorpharma Int | Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica |
JP3142919B2 (ja) | 1991-11-06 | 2001-03-07 | 旭化成株式会社 | セルロース誘導体ラテックス及びその製法 |
US5160742A (en) | 1991-12-31 | 1992-11-03 | Abbott Laboratories | System for delivering an active substance for sustained release |
US5229137A (en) † | 1992-05-06 | 1993-07-20 | Brigham And Women's Hospital, Inc. | Methods and pharmaceutical compositions for treating episodic heartburn |
US5447918A (en) | 1992-07-27 | 1995-09-05 | Mccullough; Ricky W. | Gastrointestinal anti-irritant composition comprising sucralfate and methods of use |
NZ253999A (en) | 1992-08-05 | 1996-07-26 | Faulding F H & Co Ltd | Pelletised substained release medicament |
US5330759A (en) | 1992-08-26 | 1994-07-19 | Sterling Winthrop Inc. | Enteric coated soft capsules and method of preparation thereof |
CA2110313C (en) † | 1992-12-01 | 2004-10-26 | Edward John Roche | Pharmaceutical compositions containing a guanidinothiazole compound and antacids |
CA2166731A1 (en) | 1993-07-06 | 1995-01-19 | Robert T. Sims | H2 antagonist-alginate-antacid combinations |
AU7218294A (en) | 1993-07-06 | 1995-02-06 | Mcneil-Ppc, Inc. | H2 antagonist-alginate combinations |
WO1995008332A1 (en) | 1993-09-20 | 1995-03-30 | The Procter & Gamble Company | Use of triclosan phosphates for the treatment of gastrointestinal disorders due to heliobacter infection |
JP3017906B2 (ja) | 1993-10-08 | 2000-03-13 | 信越化学工業株式会社 | 腸溶性コーティング剤分散液 |
KR100353384B1 (ko) † | 1993-10-12 | 2002-12-28 | 미쯔비시 도꾜 세이야꾸 가부시끼가이샤 | 장용성과립함유정제 |
GB2285989A (en) | 1994-01-28 | 1995-08-02 | Merck Frosst Canada Inc | Aqueous formulations for enteric coatings |
AUPM596894A0 (en) | 1994-05-30 | 1994-06-23 | Hybrid Scientific Pty Ltd | Composition for treating gastrointestinal disorders - a combination of bismuth salts plus lactobacillus or bifidobacteria species bacteria for treating gastrointestinal disorders |
SE9402431D0 (sv) | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
SK283626B6 (sk) | 1994-07-08 | 2003-10-07 | Astrazeneca Ab | Multijednotková tabletovaná dávková forma, spôsob jej prípravy a jej použitie |
AUPM695294A0 (en) | 1994-07-20 | 1994-08-11 | Borody, Thomas Julius | Improved combination therapy dose unit |
DE69614097T2 (de) | 1995-03-17 | 2002-03-14 | The Boots Co., Plc | Flüssige pharmazeutische zusammensetzungen mit pektin |
US5824339A (en) † | 1995-09-08 | 1998-10-20 | Takeda Chemical Industries, Ltd | Effervescent composition and its production |
SE9600071D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
JP2001509791A (ja) | 1996-11-27 | 2001-07-24 | ザ、プロクター、エンド、ギャンブル、カンパニー | 胃腸障害の治療用組成物及び方法 |
-
1996
- 1996-01-08 SE SE9600071A patent/SE9600071D0/xx unknown
- 1996-12-20 BR BRPI9607350-0A patent/BR9607350B1/pt not_active IP Right Cessation
- 1996-12-20 CN CN96193594A patent/CN1080125C/zh not_active Expired - Fee Related
- 1996-12-20 CA CA002213996A patent/CA2213996C/en not_active Expired - Fee Related
- 1996-12-20 TR TR97/00916T patent/TR199700916T1/tr unknown
- 1996-12-20 IL IL12165196A patent/IL121651A/xx not_active IP Right Cessation
- 1996-12-20 US US08/750,934 patent/US6183776B1/en not_active Expired - Lifetime
- 1996-12-20 KR KR1019970706236A patent/KR100490075B1/ko not_active IP Right Cessation
- 1996-12-20 PT PT96944726T patent/PT813424E/pt unknown
- 1996-12-20 UA UA97104949A patent/UA45392C2/uk unknown
- 1996-12-20 JP JP9525131A patent/JPH11501950A/ja active Pending
- 1996-12-20 DE DE69624907T patent/DE69624907T3/de not_active Expired - Lifetime
- 1996-12-20 DK DK96944726T patent/DK0813424T4/da active
- 1996-12-20 NZ NZ325977A patent/NZ325977A/xx not_active IP Right Cessation
- 1996-12-20 HU HU9904024A patent/HU229153B1/hu not_active IP Right Cessation
- 1996-12-20 RU RU97116726/14A patent/RU2179453C2/ru not_active IP Right Cessation
- 1996-12-20 EP EP96944726A patent/EP0813424B2/en not_active Expired - Lifetime
- 1996-12-20 WO PCT/SE1996/001737 patent/WO1997025066A1/en active IP Right Grant
- 1996-12-20 SK SK1169-97A patent/SK283695B6/sk not_active IP Right Cessation
- 1996-12-20 PL PL96322175A patent/PL187075B1/pl not_active IP Right Cessation
- 1996-12-20 CZ CZ19972747A patent/CZ293583B6/cs not_active IP Right Cessation
- 1996-12-20 AT AT96944726T patent/ATE228009T1/de active
- 1996-12-20 ES ES96944726T patent/ES2185817T5/es not_active Expired - Lifetime
- 1996-12-20 MX MX9706785A patent/MX9706785A/es not_active IP Right Cessation
- 1996-12-20 EE EE9700192A patent/EE04002B1/xx not_active IP Right Cessation
- 1996-12-20 AU AU13241/97A patent/AU712669B2/en not_active Ceased
- 1996-12-26 AR ARP960105899A patent/AR005281A1/es not_active Application Discontinuation
- 1996-12-27 TW TW085116139A patent/TW464514B/zh not_active IP Right Cessation
- 1996-12-30 ZA ZA9610935A patent/ZA9610935B/xx unknown
-
1997
- 1997-01-07 MY MYPI97000065A patent/MY116091A/en unknown
- 1997-01-07 EG EG1897A patent/EG23821A/xx active
- 1997-01-15 SA SA97170553A patent/SA97170553B1/ar unknown
- 1997-08-20 IS IS4548A patent/IS2716B/is unknown
- 1997-09-04 NO NO19974071A patent/NO326656B1/no not_active IP Right Cessation
-
1998
- 1998-02-05 HK HK98100847A patent/HK1001763A1/xx not_active IP Right Cessation
- 1998-11-06 HK HK98111792A patent/HK1017992A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA9610935B (en) | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate | |
IL121652A0 (en) | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent | |
ZA9610936B (en) | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid | |
AP9801173A0 (en) | Rapidly releasing and taste-making pharmaceutical dosage | |
AU6475901A (en) | System and method for assessing the performance of a pharmaceutical agent delivery system | |
EP1073490A4 (en) | DEVICE FOR DISCHARGING A MEDICINE AND RELATED METHODS | |
DK1009454T3 (da) | Dental bedövelsesmiddel og tilförselsinjektionsenhed | |
HUP0202338A2 (en) | Pharmaceutical composition containing fenofibrate and preparation method | |
HK1018211A1 (en) | Pharmaceutical combination preparation of an inhibitor of the sodium/dydrogen exchanger and a medicament for the treatment of cardiovascular diseases. | |
HUP0000963A3 (en) | The use of levobupivacaine in paediatric surgery | |
CZ2000522A3 (cs) | Farmaceutický prostředek na bázi piperidinalkanolového antihistaminika a použití | |
HUP0200812A3 (en) | Vitamin d analogues and their pharmaceutical use | |
GB9826676D0 (en) | Imaging and therapeutic agent delivery | |
GB9408014D0 (en) | Analgesic agent and its use | |
ZA977873B (en) | Dosage form and method for administering drug. | |
ZA98805B (en) | Active delivery device and related procedures | |
AUPM570194A0 (en) | Drug dosage calculation device & software | |
GB9626215D0 (en) | A therapeutic agent and its use | |
PL301872A1 (en) | Generally tonizing and immunostimulating pharmaceutical agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
AM43 | Amendment of standard patent following opposition or revocation proceedings in the designated patent office (acc. sect 43 patent ordinance) | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20131220 |